Back to Search Start Over

Multiple Functions Integrated inside a Single Molecule for Amplification of Photodynamic Therapy Activity.

Authors :
Shi X
Zhan Q
Li Y
Zhou L
Wei S
Source :
Molecular pharmaceutics [Mol Pharm] 2020 Jan 06; Vol. 17 (1), pp. 190-201. Date of Electronic Publication: 2019 Dec 17.
Publication Year :
2020

Abstract

Nitric oxide (NO) can play both prosurvival and prodeath roles in photodynamic therapy (PDT). The generation efficiency of peroxynitrite anions (ONOO <superscript>-</superscript> ), by NO and superoxide anions (O <subscript>2</subscript> <superscript>•-</superscript> ), significantly influenced the outcome. Reports indicated that such efficiency is closely related to the distance between NO and O <subscript>2</subscript> <superscript>•-</superscript> . Thus, in this manuscript, l-arginine (Arg) ethyl ester-modified zinc phthalocyanine (Arg-ZnPc) was designed and synthesized as a photosensitizer (PS) and NO donor. Post light irradiation, the guanido of Arg-ZnPc can be effectively oxidized by the generated reactive oxygen species (ROS) in the PDT process to release NO. Such a strategy could ensure O <subscript>2</subscript> <superscript>•-</superscript> and NO generation in the same place at the same time to guarantee effective ONOO <superscript>-</superscript> formation. In addition, NO has other multiple synergistic cancer treatment functions, including tumor tissue vasodilatation for drug extravasation promotion, P-glycoprotein (P-gp) downregulation for drug efflux inhibition, and glutathione depletion for cancer cell endogenous antioxidant defense destruction. In vitro and in vivo results indicated that the effective ONOO <superscript>-</superscript> formation and multiple functions of Arg-ZnPc could synergistically enhance its PDT activity and ensure satisfactory cancer treatment outcome.

Details

Language :
English
ISSN :
1543-8392
Volume :
17
Issue :
1
Database :
MEDLINE
Journal :
Molecular pharmaceutics
Publication Type :
Academic Journal
Accession number :
31804837
Full Text :
https://doi.org/10.1021/acs.molpharmaceut.9b00893